COVID-19 and readjusting clinical trials
In addition to researchers who formulate the protocol for the trial and work to secure funding (either from governments, foundations, pharmaceutical or device manufacturers, or a combination of the above), clinical trials include clinical caregivers and nurses who work with patients at clinical tria...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2020-08, Vol.396 (10250), p.523-524 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 524 |
|---|---|
| container_issue | 10250 |
| container_start_page | 523 |
| container_title | The Lancet (British edition) |
| container_volume | 396 |
| creator | van Dorn, Aaron |
| description | In addition to researchers who formulate the protocol for the trial and work to secure funding (either from governments, foundations, pharmaceutical or device manufacturers, or a combination of the above), clinical trials include clinical caregivers and nurses who work with patients at clinical trial sites, postgraduate researchers, postdoctoral fellows, research scientists, and others who work on the analysis of data generated by the trial, some of whom may or may not interact with patients, but all of whom are essential to the final result. Fergus Sweeney, head of clinical studies and manufacturing at the European Medicines Agency, told The Lancet that one of the key parts of their guidance has been physical distancing to protect patients and clinic staff, but ensuring the safety of patients in testing and treatment is also important. “The rapidity with which new information, new data becomes available, new studies become published…is quite impressive. Since the emergence of COVID-19 in December, 2019, 2995 clinical trials related to COVID-19 have been registered with ClinicalTrials.gov. |
| doi_str_mv | 10.1016/S0140-6736(20)31787-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673620317876</els_id><sourcerecordid>2435739046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4906-81f3fd6bd311288b18f12e99c03b4acdec0c5b1671b10c20d426739634869a83</originalsourceid><addsrcrecordid>eNqFkUFP3DAQha2qFbul_QlFK_WyHAIztuM4FxBa2oKExIFV1Zvl2A71KpssdoLEv8fZhVXh0tMc_M3zm_cI-YZwgoDi9A6QQyYKJuYUjhkWssjEBzJFXvAs58Wfj2S6Rybkc4wrAOAC8gMyYVRSiRKmZL64_X19mWE5062dBaftaoi9b-9npvGtN7qZ9cHrJn4hn-o03NeXeUiWP38sF1fZze2v68XFTWZ4CSKTWLPaisoyRCplhbJG6srSAKu4NtYZMHmFosAKwVCwnCaDpWBcilJLdkjOdrKboVo7a1zbB92oTfBrHZ5Up716-9L6v-q-e1QF5yDFKDB_EQjdw-Bir9Y-Gtc0unXdEBXlTMgilwIT-v0duuqG0KbrRipPtlJeicp3lAldjMHVezMIaqxCbatQY86KgtpWoca9o38v2W-9Zp-A8x3gUpyP3gUVjXetcdYHZ3plO_-fL54Bj0WV_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435739046</pqid></control><display><type>article</type><title>COVID-19 and readjusting clinical trials</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>van Dorn, Aaron</creator><creatorcontrib>van Dorn, Aaron</creatorcontrib><description>In addition to researchers who formulate the protocol for the trial and work to secure funding (either from governments, foundations, pharmaceutical or device manufacturers, or a combination of the above), clinical trials include clinical caregivers and nurses who work with patients at clinical trial sites, postgraduate researchers, postdoctoral fellows, research scientists, and others who work on the analysis of data generated by the trial, some of whom may or may not interact with patients, but all of whom are essential to the final result. Fergus Sweeney, head of clinical studies and manufacturing at the European Medicines Agency, told The Lancet that one of the key parts of their guidance has been physical distancing to protect patients and clinic staff, but ensuring the safety of patients in testing and treatment is also important. “The rapidity with which new information, new data becomes available, new studies become published…is quite impressive. Since the emergence of COVID-19 in December, 2019, 2995 clinical trials related to COVID-19 have been registered with ClinicalTrials.gov.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(20)31787-6</identifier><identifier>PMID: 32828180</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Betacoronavirus ; Clinical trials ; Clinical Trials as Topic - organization & administration ; Coronavirus Infections - epidemiology ; Coronaviruses ; COVID-19 ; Emergency medical care ; Humans ; Medical research ; Pandemics ; Patient safety ; Patients ; Pneumonia, Viral - epidemiology ; SARS-CoV-2 ; Telemedicine ; World Report</subject><ispartof>The Lancet (British edition), 2020-08, Vol.396 (10250), p.523-524</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020. Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4906-81f3fd6bd311288b18f12e99c03b4acdec0c5b1671b10c20d426739634869a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2435739046?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32828180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Dorn, Aaron</creatorcontrib><title>COVID-19 and readjusting clinical trials</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>In addition to researchers who formulate the protocol for the trial and work to secure funding (either from governments, foundations, pharmaceutical or device manufacturers, or a combination of the above), clinical trials include clinical caregivers and nurses who work with patients at clinical trial sites, postgraduate researchers, postdoctoral fellows, research scientists, and others who work on the analysis of data generated by the trial, some of whom may or may not interact with patients, but all of whom are essential to the final result. Fergus Sweeney, head of clinical studies and manufacturing at the European Medicines Agency, told The Lancet that one of the key parts of their guidance has been physical distancing to protect patients and clinic staff, but ensuring the safety of patients in testing and treatment is also important. “The rapidity with which new information, new data becomes available, new studies become published…is quite impressive. Since the emergence of COVID-19 in December, 2019, 2995 clinical trials related to COVID-19 have been registered with ClinicalTrials.gov.</description><subject>Betacoronavirus</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic - organization & administration</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Emergency medical care</subject><subject>Humans</subject><subject>Medical research</subject><subject>Pandemics</subject><subject>Patient safety</subject><subject>Patients</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>SARS-CoV-2</subject><subject>Telemedicine</subject><subject>World Report</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUFP3DAQha2qFbul_QlFK_WyHAIztuM4FxBa2oKExIFV1Zvl2A71KpssdoLEv8fZhVXh0tMc_M3zm_cI-YZwgoDi9A6QQyYKJuYUjhkWssjEBzJFXvAs58Wfj2S6Rybkc4wrAOAC8gMyYVRSiRKmZL64_X19mWE5062dBaftaoi9b-9npvGtN7qZ9cHrJn4hn-o03NeXeUiWP38sF1fZze2v68XFTWZ4CSKTWLPaisoyRCplhbJG6srSAKu4NtYZMHmFosAKwVCwnCaDpWBcilJLdkjOdrKboVo7a1zbB92oTfBrHZ5Up716-9L6v-q-e1QF5yDFKDB_EQjdw-Bir9Y-Gtc0unXdEBXlTMgilwIT-v0duuqG0KbrRipPtlJeicp3lAldjMHVezMIaqxCbatQY86KgtpWoca9o38v2W-9Zp-A8x3gUpyP3gUVjXetcdYHZ3plO_-fL54Bj0WV_g</recordid><startdate>20200822</startdate><enddate>20200822</enddate><creator>van Dorn, Aaron</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200822</creationdate><title>COVID-19 and readjusting clinical trials</title><author>van Dorn, Aaron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4906-81f3fd6bd311288b18f12e99c03b4acdec0c5b1671b10c20d426739634869a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic - organization & administration</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Emergency medical care</topic><topic>Humans</topic><topic>Medical research</topic><topic>Pandemics</topic><topic>Patient safety</topic><topic>Patients</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>SARS-CoV-2</topic><topic>Telemedicine</topic><topic>World Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Dorn, Aaron</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Dorn, Aaron</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 and readjusting clinical trials</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2020-08-22</date><risdate>2020</risdate><volume>396</volume><issue>10250</issue><spage>523</spage><epage>524</epage><pages>523-524</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>In addition to researchers who formulate the protocol for the trial and work to secure funding (either from governments, foundations, pharmaceutical or device manufacturers, or a combination of the above), clinical trials include clinical caregivers and nurses who work with patients at clinical trial sites, postgraduate researchers, postdoctoral fellows, research scientists, and others who work on the analysis of data generated by the trial, some of whom may or may not interact with patients, but all of whom are essential to the final result. Fergus Sweeney, head of clinical studies and manufacturing at the European Medicines Agency, told The Lancet that one of the key parts of their guidance has been physical distancing to protect patients and clinic staff, but ensuring the safety of patients in testing and treatment is also important. “The rapidity with which new information, new data becomes available, new studies become published…is quite impressive. Since the emergence of COVID-19 in December, 2019, 2995 clinical trials related to COVID-19 have been registered with ClinicalTrials.gov.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32828180</pmid><doi>10.1016/S0140-6736(20)31787-6</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2020-08, Vol.396 (10250), p.523-524 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440868 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Betacoronavirus Clinical trials Clinical Trials as Topic - organization & administration Coronavirus Infections - epidemiology Coronaviruses COVID-19 Emergency medical care Humans Medical research Pandemics Patient safety Patients Pneumonia, Viral - epidemiology SARS-CoV-2 Telemedicine World Report |
| title | COVID-19 and readjusting clinical trials |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A48%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20and%20readjusting%20clinical%20trials&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=van%20Dorn,%20Aaron&rft.date=2020-08-22&rft.volume=396&rft.issue=10250&rft.spage=523&rft.epage=524&rft.pages=523-524&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(20)31787-6&rft_dat=%3Cproquest_pubme%3E2435739046%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435739046&rft_id=info:pmid/32828180&rft_els_id=S0140673620317876&rfr_iscdi=true |